Perceptive Advisors’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $34.2M | Sell |
|
|||||
|
2025
Q1 | $48.6M | Buy |
|
|||||
|
2024
Q4 | $53M | Sell |
|
|||||
|
2024
Q3 | $67.8M | Buy |
|
|||||
|
2024
Q2 | $50.8M | Sell |
|
|||||
|
2024
Q1 | $95.7M | Buy |
|
|||||
|
2023
Q4 | $98.1M | Sell |
|
|||||
|
2023
Q3 | $146M | Buy |
|
|||||
|
2023
Q2 | $47.9M | Buy |
|
|||||
|
2023
Q1 | $20M | Buy |
|
|||||
|
2022
Q4 | $2.66M | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $64.7M | Hold |
|
|||||
|
2020
Q3 | $49.3M | Buy |
|
|||||
|
2020
Q2 | $26.8M | Buy |
|